Strata Skin Sciences Inc. logo

Strata Skin Sciences Inc. (E2O)

Market Closed
15 Jun, 20:00
XMUN XMUN
2. 83
0
0%
9.9M Market Cap
- P/E Ratio
- Div Yield
0 Volume
-0.19 Eps
2.83
Previous Close
Add Transaction
Day Range
2.83 2.83
Year Range
2.83 2.83
Want to track E2O and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

E2O closed yesterday higher at €2.83, an increase of 0% from Friday's close, completing a monthly increase of 0% or €0. Over the past 12 months, E2O stock gained 0%.
E2O is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.1667%, based on the last three reports.
Strata Skin Sciences Inc. has completed 1 stock splits, with the recent split occurring on Jun 07, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

E2O Chart

People also search for

GOODNESS GROWTH HLDGS INC
11.05
0%
9HP
Spinnova Oyj
0.46
-1.1765%
8TE
Cannabis Poland S.A.
0.02
+6.5217%
25I
ImmuPharma PLC
0.05
0%
ExpreS2ion Biotech Holding AB
0.14
0%
SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy

SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy

STRATA Skin Sciences plunges 8% despite new meta-analysis backing its 308 nm excimer laser with up to 85% PASI improvement in plaque psoriasis.

Zacks | 3 months ago
STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. (SSKN) Q3 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. ( SSKN ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Financial Officer & Chief Accounting Officer Conference Call Participants Jules Abraham - CorProminence, LLC Destiny Buch - Ladenburg Thalmann & Co. Inc., Research Division Jeremy Pearlman - Maxim Group LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences, Inc. Third Quarter 2025 Financial Results and Corporate Update Conference Call.

Seekingalpha | 7 months ago
STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. (SSKN) Q2 2025 Earnings Call Transcript

STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Dolev Rafaeli - President, CEO & Vice-Chairman John Gillings - Principal Financial Officer & Chief Accounting Officer Conference Call Participants Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division Jeremy Pearlman - Maxim Group LLC, Research Division Jules Abraham - CorProminence, LLC Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences Inc. Second Quarter 2025 Financial Results and Corporate Update Conference Call.

Seekingalpha | 10 months ago

Strata Skin Sciences Inc. (E2O) FAQ

What is the stock price today?

The current price is €2.83.

On which exchange is it traded?

Strata Skin Sciences Inc. is listed on XMUN.

What is its stock symbol?

The ticker symbol is E2O.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 9.9M.

Has Strata Skin Sciences Inc. ever had a stock split?

Strata Skin Sciences Inc. had 1 splits and the recent split was on Jun 07, 2024.

Strata Skin Sciences Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Dolev Rafaeli CEO
XMUN Exchange
US86272A3059 ISIN
US Country
106 Employees
- Last Dividend
10 Jul 2014 Last Split
28 Oct 2005 IPO Date

Overview

STRATA Skin Sciences, Inc. is a pioneering medical technology company dedicated to developing, commercializing, and marketing innovative products for treating dermatological conditions. Specifically focusing on the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America, STRATA operates through two main segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company has transitioned from its former identity, MELA Sciences, Inc., embracing its new name, STRATA Skin Sciences, Inc., in January 2016. With its foundation laid in 1989, and headquartering in Horsham, Pennsylvania, STRATA has established a significant footprint in the medical field, aiming to improve patient outcomes and quality of life through its innovative dermatology solutions.

Products and Services

  • XTRAC and Pharos Excimer Lasers
  • These excimer laser systems are at the forefront of STRATA’s offerings, designed to provide targeted phototherapy treatment for psoriasis, vitiligo, and other skin conditions. By using a specific wavelength of UV light, these lasers can effectively treat affected skin areas without harming the surrounding healthy tissue, offering a non-invasive treatment option with minimal side effects.

  • VTRAC Lamp Systems
  • Similar to the excimer lasers, the VTRAC lamp systems are developed for the treatment of skin conditions such as psoriasis and vitiligo. These lamp systems utilize a specific form of light therapy to target and treat skin lesions, providing another effective, non-invasive treatment option for patients suffering from these chronic conditions.

  • TheraClear Acne Therapy System
  • Addressing the widespread condition of acne, the TheraClear Acne Therapy System is designed for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. This system combines light therapy with vacuum technology to deeply cleanse and purify the skin, targeting and eliminating acne-causing bacteria, reducing inflammation, and promoting a clearer, healthier-looking complexion.

Contact Information

Address: 5 Walnut Grove Drive
Phone: 215 619 3200